Dapagliflozin in patients with type 1 diabetes: A post hoc analysis of the effect of insulin dose adjustments on 24‐hour continuously monitored mean glucose and fasting β‐hydroxybutyrate levels in a phase IIa pilot study

    loading  Checking for direct PDF access through Ovid


Abstract unavailable for this article.

Related Topics

    loading  Loading Related Articles